var eventsData = [{"Ticker":"CVX","EffectiveDate":"2017-01-27","Type":"EarningsRevenueMiss","Title":"Before market open, CVX reports 2016 Q4's earning $0.22 per share and revenue $31497MM. This misses analyst's estimated EPS $0.66, misses estimated revenue $33850MM.","DailyReturn":-0.023681,"FiveDayReturnAfter":-0.037949,"FiveDayReturnBefore":0.008357},{"Ticker":"CVX","EffectiveDate":"2017-01-10","Type":"RatingNeutral","Title":"HSBC downgrades CVX to Hold from Buy.","DailyReturn":-0.007597,"FiveDayReturnAfter":0.003792,"FiveDayReturnBefore":-0.01593},{"Ticker":"CVX","EffectiveDate":"2017-01-04","Type":"RatingUpgrade","Title":"Bank of America upgrades CVX to Buy from Neutral.","DailyReturn":-0.000255,"FiveDayReturnAfter":-0.024829,"FiveDayReturnBefore":-0.004825},{"Ticker":"CVX","EffectiveDate":"2016-12-15","Type":"RatingUpgrade","Title":"Macquarie upgrades CVX to Outperform. Target Price is $130; previously $90.","DailyReturn":0.0094,"FiveDayReturnAfter":0.016677,"FiveDayReturnBefore":0.013196},{"Ticker":"CVX","EffectiveDate":"2016-12-01","Type":"RatingUpgrade","Title":"Independent Research upgrades CVX to Buy from Hold.","DailyReturn":0.015507,"FiveDayReturnAfter":0.025488,"FiveDayReturnBefore":0.008462},{"Ticker":"CVX","EffectiveDate":"2016-11-16","Type":"Dividend","Title":"The Firm pays dividend $1.08","DailyReturn":0.004357,"FiveDayReturnAfter":0.025081,"FiveDayReturnBefore":0.015446},{"Ticker":"CVX","EffectiveDate":"2016-11-15","Type":"RatingUpgrade","Title":"CLSA upgrades CVX to Buy from Outperform.","DailyReturn":0.022235,"FiveDayReturnAfter":0.043087,"FiveDayReturnBefore":-0.002435},{"Ticker":"CVX","EffectiveDate":"2016-11-01","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades CVX to Overweight from Equal-Weight.","DailyReturn":0.016516,"FiveDayReturnAfter":0.019849,"FiveDayReturnBefore":0.039828},{"Ticker":"CVX","EffectiveDate":"2016-10-31","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CVX to Buy from Neutral.","DailyReturn":0.008958,"FiveDayReturnAfter":0.009204,"FiveDayReturnBefore":0.024572},{"Ticker":"CVX","EffectiveDate":"2016-10-28","Type":"EarningsRevenueBeat","Title":"Before market open, CVX reports 2016 Q3's earning $0.68 per share and revenue $30140MM. This beats analyst's estimated EPS $0.45, beats estimated revenue $29050MM.","DailyReturn":0.039031,"FiveDayReturnAfter":0.053298,"FiveDayReturnBefore":-0.019328},{"Ticker":"CVX","EffectiveDate":"2016-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.039031,"FiveDayReturnAfter":0.053298,"FiveDayReturnBefore":-0.019328},{"Ticker":"CVX","EffectiveDate":"2016-10-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.00277,"FiveDayReturnAfter":0.002174,"FiveDayReturnBefore":-0.011703},{"Ticker":"CVX","EffectiveDate":"2016-09-13","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on CVX to Outperform. Target Price is $120.","DailyReturn":-0.027579,"FiveDayReturnAfter":-0.042045,"FiveDayReturnBefore":0.012993},{"Ticker":"CVX","EffectiveDate":"2016-08-17","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.006598,"FiveDayReturnAfter":0.001279,"FiveDayReturnBefore":0.012749},{"Ticker":"CVX","EffectiveDate":"2016-08-09","Type":"RatingUpgrade","Title":"PiperJaffray upgrades CVX to Overweight from Neutral.","DailyReturn":0.001186,"FiveDayReturnAfter":0.015395,"FiveDayReturnBefore":0.020868},{"Ticker":"CVX","EffectiveDate":"2016-08-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.006865,"FiveDayReturnAfter":0.016284,"FiveDayReturnBefore":-0.019411},{"Ticker":"CVX","EffectiveDate":"2016-08-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.006865,"FiveDayReturnAfter":0.016284,"FiveDayReturnBefore":-0.019411},{"Ticker":"CVX","EffectiveDate":"2016-07-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.006779,"FiveDayReturnAfter":-0.013849,"FiveDayReturnBefore":-0.034755},{"Ticker":"CVX","EffectiveDate":"2016-07-29","Type":"EarningsRevenueBeat","Title":"Before market open, CVX reports 2016 Q2's earning $0.49 per share and revenue $29282MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $28540MM.","DailyReturn":0.006779,"FiveDayReturnAfter":-0.013849,"FiveDayReturnBefore":-0.034755},{"Ticker":"CVX","EffectiveDate":"2016-07-11","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $116; previously $114.","DailyReturn":0.005918,"FiveDayReturnAfter":0.021343,"FiveDayReturnBefore":-0.000573},{"Ticker":"CVX","EffectiveDate":"2016-05-25","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.01577,"FiveDayReturnAfter":0.009338,"FiveDayReturnBefore":-0.005574},{"Ticker":"CVX","EffectiveDate":"2016-05-17","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":-0.004643,"FiveDayReturnAfter":-0.018346,"FiveDayReturnBefore":0.019147},{"Ticker":"CVX","EffectiveDate":"2016-05-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.015386,"FiveDayReturnAfter":0.00104,"FiveDayReturnBefore":-0.011057},{"Ticker":"CVX","EffectiveDate":"2016-05-16","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.015386,"FiveDayReturnAfter":0.00104,"FiveDayReturnBefore":-0.011057},{"Ticker":"CVX","EffectiveDate":"2016-04-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.002148,"FiveDayReturnAfter":-0.009616,"FiveDayReturnBefore":0.009816},{"Ticker":"CVX","EffectiveDate":"2016-04-29","Type":"EarningsMissRevenueBeat","Title":"Before market open, CVX reports 2016 Q1's earning $-0.39 per share and revenue $23553MM. This misses analyst's estimated EPS $-0.1, beats estimated revenue $22210MM.","DailyReturn":-0.002148,"FiveDayReturnAfter":-0.009616,"FiveDayReturnBefore":0.009816},{"Ticker":"CVX","EffectiveDate":"2016-04-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.015251,"FiveDayReturnAfter":-0.009526,"FiveDayReturnBefore":0.017655},{"Ticker":"CVX","EffectiveDate":"2016-04-08","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $97; previously $89.","DailyReturn":0.016246,"FiveDayReturnAfter":0.033098,"FiveDayReturnBefore":-0.006414},{"Ticker":"CVX","EffectiveDate":"2016-03-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.000734,"FiveDayReturnAfter":-0.028193,"FiveDayReturnBefore":-0.011682},{"Ticker":"CVX","EffectiveDate":"2016-03-22","Type":"RatingNeutral","Title":"Raymond James downgrades CVX to Market Perform from Outperform.","DailyReturn":-0.009747,"FiveDayReturnAfter":-0.011682,"FiveDayReturnBefore":0.022863},{"Ticker":"CVX","EffectiveDate":"2016-03-18","Type":"RatingNeutral","Title":"Nomura initiates coverage on CVX to Neutral. Target Price is $85.","DailyReturn":0.008257,"FiveDayReturnAfter":-0.021281,"FiveDayReturnBefore":0.03092},{"Ticker":"CVX","EffectiveDate":"2016-03-18","Type":"RatingNeutral","Title":"Goldman Sachs maintains CVX to Neutral. Target Price is $96; previously $94.","DailyReturn":0.008257,"FiveDayReturnAfter":-0.021281,"FiveDayReturnBefore":0.03092},{"Ticker":"CVX","EffectiveDate":"2016-03-11","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CVX to Neutral from Sell.","DailyReturn":0.006813,"FiveDayReturnAfter":0.03092,"FiveDayReturnBefore":0.070674},{"Ticker":"CVX","EffectiveDate":"2016-03-09","Type":"RatingUpgrade","Title":"Wolfe Research upgrades CVX to Outperform from Peer Perform.","DailyReturn":0.045977,"FiveDayReturnAfter":0.060452,"FiveDayReturnBefore":0.029853},{"Ticker":"CVX","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"RBC Capital maintains CVX to Sector Perform. Target Price is $90; previously $84.","DailyReturn":0.045977,"FiveDayReturnAfter":0.060452,"FiveDayReturnBefore":0.029853},{"Ticker":"CVX","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Neutral. Target Price is $96; previously $84.","DailyReturn":0.045977,"FiveDayReturnAfter":0.060452,"FiveDayReturnBefore":0.029853},{"Ticker":"CVX","EffectiveDate":"2016-02-16","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.005334,"FiveDayReturnAfter":0.051519,"FiveDayReturnBefore":0.030303},{"Ticker":"CVX","EffectiveDate":"2016-01-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.006401,"FiveDayReturnAfter":-0.013238,"FiveDayReturnBefore":0.058351},{"Ticker":"CVX","EffectiveDate":"2016-01-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.006401,"FiveDayReturnAfter":-0.013238,"FiveDayReturnBefore":0.058351},{"Ticker":"CVX","EffectiveDate":"2016-01-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.009867,"FiveDayReturnAfter":-0.034836,"FiveDayReturnBefore":0.031519},{"Ticker":"CVX","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Baird initiates coverage on CVX to Outperform. Target Price is $108.","DailyReturn":0.026209,"FiveDayReturnAfter":0.053134,"FiveDayReturnBefore":-0.039352},{"Ticker":"CVX","EffectiveDate":"2016-01-07","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVX to Buy. Target Price is $103; previously $106.","DailyReturn":-0.035436,"FiveDayReturnAfter":-0.056645,"FiveDayReturnBefore":-0.058442},{"Ticker":"CVX","EffectiveDate":"2015-12-16","Type":"RatingUpgrade","Title":"Argus Research upgrades CVX to Buy from Hold.","DailyReturn":0.007331,"FiveDayReturnAfter":-0.027211,"FiveDayReturnBefore":0.070565},{"Ticker":"CVX","EffectiveDate":"2015-12-15","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Overweight. Target Price is $91; previously $94.","DailyReturn":0.038397,"FiveDayReturnAfter":-0.001009,"FiveDayReturnBefore":0.023216},{"Ticker":"CVX","EffectiveDate":"2015-12-02","Type":"RatingUpgrade","Title":"Citigroup upgrades CVX to Buy from Neutral. Target Price is $110; previously $95.","DailyReturn":-0.024113,"FiveDayReturnAfter":-0.067542,"FiveDayReturnBefore":0.027072},{"Ticker":"CVX","EffectiveDate":"2015-11-17","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.004593,"FiveDayReturnAfter":-0.015871,"FiveDayReturnBefore":0.002671},{"Ticker":"CVX","EffectiveDate":"2015-11-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.004593,"FiveDayReturnAfter":-0.015871,"FiveDayReturnBefore":0.002671},{"Ticker":"CVX","EffectiveDate":"2015-11-16","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.043831,"FiveDayReturnAfter":0.015855,"FiveDayReturnBefore":-0.05858},{"Ticker":"CVX","EffectiveDate":"2015-11-03","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades CVX to Buy from Hold.","DailyReturn":0.033488,"FiveDayReturnAfter":-0.028195,"FiveDayReturnBefore":0.067405},{"Ticker":"CVX","EffectiveDate":"2015-11-02","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Neutral. Target Price is $100; previously $87.","DailyReturn":0.044894,"FiveDayReturnAfter":0.034073,"FiveDayReturnBefore":-0.003954},{"Ticker":"CVX","EffectiveDate":"2015-10-30","Type":"EarningsRevenueBeat","Title":"Before market open, CVX reports 2015 Q3's earning $1.09 per share and revenue $34315MM. This beats analyst's estimated EPS $0.78, beats estimated revenue $29880MM.","DailyReturn":0.011013,"FiveDayReturnAfter":0.050541,"FiveDayReturnBefore":-0.019064},{"Ticker":"CVX","EffectiveDate":"2015-10-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.011013,"FiveDayReturnAfter":0.050541,"FiveDayReturnBefore":-0.019064},{"Ticker":"CVX","EffectiveDate":"2015-10-12","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $96; previously $99.","DailyReturn":-0.009267,"FiveDayReturnAfter":0.019019,"FiveDayReturnBefore":0.093804},{"Ticker":"CVX","EffectiveDate":"2015-09-30","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.034492,"FiveDayReturnAfter":0.131776,"FiveDayReturnBefore":-0.01303},{"Ticker":"CVX","EffectiveDate":"2015-09-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.034492,"FiveDayReturnAfter":0.131776,"FiveDayReturnBefore":-0.01303},{"Ticker":"CVX","EffectiveDate":"2015-09-25","Type":"RatingUpgrade","Title":"Wolfe Research upgrades CVX to Peer Perform from Underperform.","DailyReturn":0.010534,"FiveDayReturnAfter":0.018681,"FiveDayReturnBefore":-0.032248},{"Ticker":"CVX","EffectiveDate":"2015-09-23","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CVX to Underperform. Target Price is $65.","DailyReturn":-0.014628,"FiveDayReturnAfter":-0.01303,"FiveDayReturnBefore":0.001037},{"Ticker":"CVX","EffectiveDate":"2015-09-11","Type":"RatingUpgrade","Title":"JP Morgan upgrades CVX to Overweight from Neutral. Target Price is $86; previously $90.","DailyReturn":0.001718,"FiveDayReturnAfter":0.048375,"FiveDayReturnBefore":-0.031227},{"Ticker":"CVX","EffectiveDate":"2015-09-08","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Neutral. Target Price is $87; previously $110.","DailyReturn":0.002217,"FiveDayReturnAfter":-0.011807,"FiveDayReturnBefore":-0.047876},{"Ticker":"CVX","EffectiveDate":"2015-08-24","Type":"RatingUpgrade","Title":"Bank of America upgrades CVX to Neutral from Underperform. Target Price is $100; previously $104.","DailyReturn":-0.048046,"FiveDayReturnAfter":0.059817,"FiveDayReturnBefore":-0.114139},{"Ticker":"CVX","EffectiveDate":"2015-08-17","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":-0.019901,"FiveDayReturnAfter":-0.114139,"FiveDayReturnBefore":0.026394},{"Ticker":"CVX","EffectiveDate":"2015-08-05","Type":"RatingNeutral","Title":"RBC Capital maintains CVX to Sector Perform. Target Price is $101; previously $102.","DailyReturn":-0.013848,"FiveDayReturnAfter":0.006668,"FiveDayReturnBefore":-0.081009},{"Ticker":"CVX","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"RBC Capital maintains CVX to Sector Perform. Target Price is $101; previously $102.","DailyReturn":-0.03255,"FiveDayReturnAfter":-0.054939,"FiveDayReturnBefore":-0.023678},{"Ticker":"CVX","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $99; previously $110.","DailyReturn":-0.03255,"FiveDayReturnAfter":-0.054939,"FiveDayReturnBefore":-0.023678},{"Ticker":"CVX","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Neutral. Target Price is $95; previously $104.","DailyReturn":-0.03255,"FiveDayReturnAfter":-0.054939,"FiveDayReturnBefore":-0.023678},{"Ticker":"CVX","EffectiveDate":"2015-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.048909,"FiveDayReturnAfter":-0.088038,"FiveDayReturnBefore":0.000968},{"Ticker":"CVX","EffectiveDate":"2015-07-07","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $110; previously $115.","DailyReturn":0.005276,"FiveDayReturnAfter":-0.001796,"FiveDayReturnBefore":-0.039618},{"Ticker":"CVX","EffectiveDate":"2015-06-16","Type":"RatingUpgrade","Title":"Societe Generale upgrades CVX to Buy from Hold.","DailyReturn":0.007554,"FiveDayReturnAfter":0.010022,"FiveDayReturnBefore":-0.011317},{"Ticker":"CVX","EffectiveDate":"2015-06-01","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVX to Buy. Target Price is $125; previously $120.","DailyReturn":-0.003592,"FiveDayReturnAfter":-0.013782,"FiveDayReturnBefore":-0.023889},{"Ticker":"CVX","EffectiveDate":"2015-05-28","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $114; previously $116.","DailyReturn":0.001261,"FiveDayReturnAfter":-0.009158,"FiveDayReturnBefore":-0.018356},{"Ticker":"CVX","EffectiveDate":"2015-05-27","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.001743,"FiveDayReturnAfter":-0.006898,"FiveDayReturnBefore":-0.032013},{"Ticker":"CVX","EffectiveDate":"2015-05-18","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CVX to Sell from Neutral. Target Price is $99; previously $111.","DailyReturn":-0.012774,"FiveDayReturnAfter":-0.029497,"FiveDayReturnBefore":0.004193},{"Ticker":"CVX","EffectiveDate":"2015-05-15","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.006053,"FiveDayReturnAfter":-0.017758,"FiveDayReturnBefore":0.008148},{"Ticker":"CVX","EffectiveDate":"2015-05-04","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $115; previously $110.","DailyReturn":-0.006603,"FiveDayReturnAfter":-0.003582,"FiveDayReturnBefore":-0.007582},{"Ticker":"CVX","EffectiveDate":"2015-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.018188,"FiveDayReturnAfter":-0.031927,"FiveDayReturnBefore":0.009864},{"Ticker":"CVX","EffectiveDate":"2015-03-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.014108,"FiveDayReturnAfter":0.007458,"FiveDayReturnBefore":0.009934},{"Ticker":"CVX","EffectiveDate":"2015-03-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.014108,"FiveDayReturnAfter":0.007458,"FiveDayReturnBefore":0.009934},{"Ticker":"CVX","EffectiveDate":"2015-03-09","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on CVX to Neutral. Target Price is $110.","DailyReturn":0.003863,"FiveDayReturnAfter":-0.018814,"FiveDayReturnBefore":-0.02978},{"Ticker":"CVX","EffectiveDate":"2015-03-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006988,"FiveDayReturnAfter":-0.018585,"FiveDayReturnBefore":-0.018338},{"Ticker":"CVX","EffectiveDate":"2015-03-03","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.006988,"FiveDayReturnAfter":-0.018585,"FiveDayReturnBefore":-0.018338},{"Ticker":"CVX","EffectiveDate":"2015-02-24","Type":"RatingNeutral","Title":"Oppenheimer downgrades CVX to Perform from Outperform.","DailyReturn":0.000927,"FiveDayReturnAfter":-0.018338,"FiveDayReturnBefore":-0.044605},{"Ticker":"CVX","EffectiveDate":"2015-02-12","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.017905,"FiveDayReturnAfter":-0.005154,"FiveDayReturnBefore":0.014931},{"Ticker":"CVX","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $111; previously $118.","DailyReturn":0.034429,"FiveDayReturnAfter":0.066774,"FiveDayReturnBefore":-0.041269},{"Ticker":"CVX","EffectiveDate":"2015-01-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.004563,"FiveDayReturnAfter":0.05946,"FiveDayReturnBefore":-0.055884},{"Ticker":"CVX","EffectiveDate":"2015-01-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.042028,"FiveDayReturnAfter":0.011663,"FiveDayReturnBefore":0.016673},{"Ticker":"CVX","EffectiveDate":"2015-01-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.042028,"FiveDayReturnAfter":0.011663,"FiveDayReturnBefore":0.016673},{"Ticker":"CVX","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Credit Suisse downgrades CVX to Neutral from Outperform.","DailyReturn":-0.019005,"FiveDayReturnAfter":-0.055884,"FiveDayReturnBefore":0.047184},{"Ticker":"CVX","EffectiveDate":"2015-01-21","Type":"RatingNeutral","Title":"Wells Fargo downgrades CVX to Market Perform.","DailyReturn":0.015873,"FiveDayReturnAfter":0.016673,"FiveDayReturnBefore":0.005557},{"Ticker":"CVX","EffectiveDate":"2015-01-15","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $125; previously $129.","DailyReturn":-0.011838,"FiveDayReturnAfter":0.047184,"FiveDayReturnBefore":-0.038146},{"Ticker":"CVX","EffectiveDate":"2015-01-14","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $115; previously $141.","DailyReturn":-0.002879,"FiveDayReturnAfter":0.037299,"FiveDayReturnBefore":-0.036096},{"Ticker":"CVX","EffectiveDate":"2015-01-05","Type":"RatingNeutral","Title":"Citigroup downgrades CVX to Neutral from Buy. Target Price is $115; previously $125.","DailyReturn":-0.039972,"FiveDayReturnAfter":-0.039591,"FiveDayReturnBefore":-0.007874},{"Ticker":"CVX","EffectiveDate":"2014-12-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.020092,"FiveDayReturnAfter":-0.050896,"FiveDayReturnBefore":-0.063454},{"Ticker":"CVX","EffectiveDate":"2014-12-10","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.020092,"FiveDayReturnAfter":-0.050896,"FiveDayReturnBefore":-0.063454},{"Ticker":"CVX","EffectiveDate":"2014-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.020092,"FiveDayReturnAfter":-0.050896,"FiveDayReturnBefore":-0.063454},{"Ticker":"CVX","EffectiveDate":"2014-12-08","Type":"RatingNeutral","Title":"Oppenheimer maintains CVX to Outperform. Target Price is $130; previously $140.","DailyReturn":-0.03671,"FiveDayReturnAfter":-0.079669,"FiveDayReturnBefore":0.018203},{"Ticker":"CVX","EffectiveDate":"2014-12-01","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Buy. Target Price is $125; previously $141.","DailyReturn":0.02627,"FiveDayReturnAfter":0.018203,"FiveDayReturnBefore":-0.074666},{"Ticker":"CVX","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Raymond James downgrades CVX to Outperform from Strong Buy. Target Price is $140.","DailyReturn":-0.008349,"FiveDayReturnAfter":-0.059503,"FiveDayReturnBefore":0.019243},{"Ticker":"CVX","EffectiveDate":"2014-11-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.002419,"FiveDayReturnAfter":0.015771,"FiveDayReturnBefore":-0.009342},{"Ticker":"CVX","EffectiveDate":"2014-11-18","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.002419,"FiveDayReturnAfter":0.015771,"FiveDayReturnBefore":-0.009342},{"Ticker":"CVX","EffectiveDate":"2014-11-14","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.008147,"FiveDayReturnAfter":0.016589,"FiveDayReturnBefore":-0.017704},{"Ticker":"CVX","EffectiveDate":"2014-11-03","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $126; previously $130.","DailyReturn":-0.026428,"FiveDayReturnAfter":-0.009633,"FiveDayReturnBefore":0.034261},{"Ticker":"CVX","EffectiveDate":"2014-10-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.023464,"FiveDayReturnAfter":0.011285,"FiveDayReturnBefore":0.008655},{"Ticker":"CVX","EffectiveDate":"2014-10-21","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $138; previously $140.","DailyReturn":0.03229,"FiveDayReturnAfter":0.031172,"FiveDayReturnBefore":-0.004833},{"Ticker":"CVX","EffectiveDate":"2014-09-23","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on CVX to Neutral. Target Price is $133.","DailyReturn":-0.003482,"FiveDayReturnAfter":-0.024095,"FiveDayReturnBefore":-0.006055},{"Ticker":"CVX","EffectiveDate":"2014-09-09","Type":"RatingNeutral","Title":"Bank of America downgrades CVX to Underperform from Neutral. Target Price is $133; previously $135.","DailyReturn":-0.008161,"FiveDayReturnAfter":-0.015732,"FiveDayReturnBefore":-0.025348},{"Ticker":"CVX","EffectiveDate":"2014-08-15","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":0.001668,"FiveDayReturnAfter":0.016074,"FiveDayReturnBefore":0.010371},{"Ticker":"CVX","EffectiveDate":"2014-08-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.005016,"FiveDayReturnAfter":0.0076,"FiveDayReturnBefore":0.014764},{"Ticker":"CVX","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.005016,"FiveDayReturnAfter":0.0076,"FiveDayReturnBefore":0.014764},{"Ticker":"CVX","EffectiveDate":"2014-08-04","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CVX to Equal-Weight from Overweight.","DailyReturn":0.002111,"FiveDayReturnAfter":-0.000312,"FiveDayReturnBefore":-0.043376},{"Ticker":"CVX","EffectiveDate":"2014-08-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.010368,"FiveDayReturnAfter":-0.02817,"FiveDayReturnBefore":-0.042491},{"Ticker":"CVX","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"Barclays maintains CVX to Equal-Weight. Target Price is $141; previously $130.","DailyReturn":-0.009492,"FiveDayReturnAfter":-0.042491,"FiveDayReturnBefore":0.036012},{"Ticker":"CVX","EffectiveDate":"2014-07-17","Type":"RatingNeutral","Title":"Deutsche Bank maintains CVX to Buy. Target Price is $157; previously $142.","DailyReturn":-0.006188,"FiveDayReturnAfter":0.022586,"FiveDayReturnBefore":-0.003813},{"Ticker":"CVX","EffectiveDate":"2014-07-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.008676,"FiveDayReturnAfter":-0.003813,"FiveDayReturnBefore":0.00649},{"Ticker":"CVX","EffectiveDate":"2014-06-10","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on CVX to Buy. Target Price is $142.","DailyReturn":0.007799,"FiveDayReturnAfter":0.03298,"FiveDayReturnBefore":0.01752},{"Ticker":"CVX","EffectiveDate":"2014-05-28","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.002605,"FiveDayReturnAfter":-0.002363,"FiveDayReturnBefore":-0.000895},{"Ticker":"CVX","EffectiveDate":"2014-05-15","Type":"Dividend","Title":"The Firm pays dividend $1.07","DailyReturn":-0.012286,"FiveDayReturnAfter":-0.009539,"FiveDayReturnBefore":0.001505},{"Ticker":"CVX","EffectiveDate":"2014-05-08","Type":"RatingNeutral","Title":"Argus Research downgrades CVX to Hold from Buy. Target Price is $130.","DailyReturn":-0.009031,"FiveDayReturnAfter":0.001505,"FiveDayReturnBefore":0.005639},{"Ticker":"CVX","EffectiveDate":"2014-05-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.001761,"FiveDayReturnAfter":0.001199,"FiveDayReturnBefore":0.005135},{"Ticker":"CVX","EffectiveDate":"2014-04-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.011036,"FiveDayReturnAfter":0.021001,"FiveDayReturnBefore":-0.010135},{"Ticker":"CVX","EffectiveDate":"2014-04-08","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CVX to Buy. Target Price is $140.","DailyReturn":0.00392,"FiveDayReturnAfter":0.011524,"FiveDayReturnBefore":-0.01329},{"Ticker":"CVX","EffectiveDate":"2014-04-03","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on CVX to Market Perform. Target Price is $125.","DailyReturn":-0.002597,"FiveDayReturnAfter":-0.002096,"FiveDayReturnBefore":0.013837},{"Ticker":"CVX","EffectiveDate":"2014-03-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.005295,"FiveDayReturnAfter":0.016181,"FiveDayReturnBefore":0.007285},{"Ticker":"CVX","EffectiveDate":"2014-02-12","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":-0.004885,"FiveDayReturnAfter":0.00902,"FiveDayReturnBefore":0.024511},{"Ticker":"CVX","EffectiveDate":"2014-01-31","Type":"RatingNeutral","Title":"S&P Capital IQ downgrades CVX to Buy from Strong Buy.","DailyReturn":-0.041391,"FiveDayReturnAfter":-0.045501,"FiveDayReturnBefore":-0.016523},{"Ticker":"CVX","EffectiveDate":"2014-01-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.041391,"FiveDayReturnAfter":-0.045501,"FiveDayReturnBefore":-0.016523},{"Ticker":"CVX","EffectiveDate":"2014-01-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.007189,"FiveDayReturnAfter":-0.052808,"FiveDayReturnBefore":-0.029681},{"Ticker":"CVX","EffectiveDate":"2014-01-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.007189,"FiveDayReturnAfter":-0.052808,"FiveDayReturnBefore":-0.029681},{"Ticker":"CVX","EffectiveDate":"2014-01-29","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.007189,"FiveDayReturnAfter":-0.052808,"FiveDayReturnBefore":-0.029681},{"Ticker":"CVX","EffectiveDate":"2014-01-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.0,"FiveDayReturnAfter":-0.033905,"FiveDayReturnBefore":-0.013054},{"Ticker":"CVX","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"Scotia Howard Weil downgrades CVX to Sector Perform from Sector Outperform.","DailyReturn":-0.014232,"FiveDayReturnAfter":-0.044972,"FiveDayReturnBefore":0.006739},{"Ticker":"CVX","EffectiveDate":"2013-12-12","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on CVX to Sector Perform. Target Price is $120.","DailyReturn":-0.009091,"FiveDayReturnAfter":-0.004104,"FiveDayReturnBefore":0.002708},{"Ticker":"CVX","EffectiveDate":"2013-12-11","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.012615,"FiveDayReturnAfter":-0.0406,"FiveDayReturnBefore":0.009263},{"Ticker":"CVX","EffectiveDate":"2013-12-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012615,"FiveDayReturnAfter":-0.0406,"FiveDayReturnBefore":0.009263},{"Ticker":"CVX","EffectiveDate":"2013-12-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.012615,"FiveDayReturnAfter":-0.0406,"FiveDayReturnBefore":0.009263},{"Ticker":"CVX","EffectiveDate":"2013-12-06","Type":"RatingNeutral","Title":"HSBC initiates coverage on CVX to Overweight. Target Price is $138.","DailyReturn":0.009827,"FiveDayReturnAfter":-0.000908,"FiveDayReturnBefore":-0.010841},{"Ticker":"CVX","EffectiveDate":"2013-11-14","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":0.003947,"FiveDayReturnAfter":0.024141,"FiveDayReturnBefore":-0.008706},{"Ticker":"CVX","EffectiveDate":"2013-11-04","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Outperform. Target Price is $140; previously $135.","DailyReturn":0.000763,"FiveDayReturnAfter":0.026591,"FiveDayReturnBefore":-0.021627},{"Ticker":"CVX","EffectiveDate":"2013-11-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.016255,"FiveDayReturnAfter":-0.000416,"FiveDayReturnBefore":-0.004989},{"Ticker":"CVX","EffectiveDate":"2013-10-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.00514,"FiveDayReturnAfter":0.012092,"FiveDayReturnBefore":-0.038568},{"Ticker":"CVX","EffectiveDate":"2013-08-15","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":-0.006609,"FiveDayReturnAfter":-0.028065,"FiveDayReturnBefore":-0.010432},{"Ticker":"CVX","EffectiveDate":"2013-08-02","Type":"EarningsRevenueMiss","Title":"Before market open, CVX reports 2013 Q2's earning $2.77 per share and revenue $55307MM. This misses analyst's estimated EPS $2.98, misses estimated revenue $56010MM.","DailyReturn":-0.011784,"FiveDayReturnAfter":-0.027014,"FiveDayReturnBefore":-0.010385},{"Ticker":"CVX","EffectiveDate":"2013-08-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.011784,"FiveDayReturnAfter":-0.027014,"FiveDayReturnBefore":-0.010385},{"Ticker":"CVX","EffectiveDate":"2013-07-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.003002,"FiveDayReturnAfter":0.006872,"FiveDayReturnBefore":0.034583},{"Ticker":"CVX","EffectiveDate":"2013-06-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.017742,"FiveDayReturnAfter":-0.004973,"FiveDayReturnBefore":-0.011286},{"Ticker":"CVX","EffectiveDate":"2013-06-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.017742,"FiveDayReturnAfter":-0.004973,"FiveDayReturnBefore":-0.011286},{"Ticker":"CVX","EffectiveDate":"2013-06-20","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on CVX to Outperform.","DailyReturn":-0.021162,"FiveDayReturnAfter":-0.019694,"FiveDayReturnBefore":0.004409},{"Ticker":"CVX","EffectiveDate":"2013-06-17","Type":"RatingNeutral","Title":"Jefferies downgrades CVX to Hold from Buy.","DailyReturn":0.007815,"FiveDayReturnAfter":-0.011286,"FiveDayReturnBefore":-0.011736},{"Ticker":"CVX","EffectiveDate":"2013-06-05","Type":"RatingNeutral","Title":"Barclays downgrades CVX to Equal-Weight from Overweight. Target Price is $145; previously $133.","DailyReturn":-0.011304,"FiveDayReturnAfter":-0.012355,"FiveDayReturnBefore":-0.02783},{"Ticker":"CVX","EffectiveDate":"2013-05-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.007435,"FiveDayReturnAfter":-0.02783,"FiveDayReturnBefore":0.013137},{"Ticker":"CVX","EffectiveDate":"2013-05-29","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.007435,"FiveDayReturnAfter":-0.02783,"FiveDayReturnBefore":0.013137},{"Ticker":"CVX","EffectiveDate":"2013-05-15","Type":"Dividend","Title":"The Firm pays dividend $1","DailyReturn":-0.007984,"FiveDayReturnAfter":0.015524,"FiveDayReturnBefore":0.015804},{"Ticker":"CVX","EffectiveDate":"2013-04-26","Type":"EarningBeat","Title":"Before market open, CVX reports 2013 Q1's earning $3.18 per share and revenue $54296MM. This beats analyst's estimated EPS $3.06.","DailyReturn":0.01291,"FiveDayReturnAfter":0.029351,"FiveDayReturnBefore":0.024949},{"Ticker":"CVX","EffectiveDate":"2013-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.01291,"FiveDayReturnAfter":0.029351,"FiveDayReturnBefore":0.024949},{"Ticker":"CVX","EffectiveDate":"2013-04-18","Type":"RatingNeutral","Title":"Jefferies maintains CVX to Buy. Target Price is $135; previously $125.","DailyReturn":0.006794,"FiveDayReturnAfter":0.029777,"FiveDayReturnBefore":-0.041209},{"Ticker":"CVX","EffectiveDate":"2013-04-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.008429,"FiveDayReturnAfter":-0.013834,"FiveDayReturnBefore":-0.00303},{"Ticker":"CVX","EffectiveDate":"2013-04-10","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVX to Overweight. Target Price is $135; previously $130.","DailyReturn":0.008429,"FiveDayReturnAfter":-0.013834,"FiveDayReturnBefore":-0.00303},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.00653,"FiveDayReturnAfter":-0.026806,"FiveDayReturnBefore":0.012644},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.00653,"FiveDayReturnAfter":-0.026806,"FiveDayReturnBefore":0.012644},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00653,"FiveDayReturnAfter":-0.026806,"FiveDayReturnBefore":0.012644},{"Ticker":"CVX","EffectiveDate":"2013-03-27","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.00653,"FiveDayReturnAfter":-0.026806,"FiveDayReturnBefore":0.012644},{"Ticker":"CVX","EffectiveDate":"2013-03-13","Type":"RatingNeutral","Title":"Bank of America maintains CVX to Neutral. Target Price is $130; previously $125.","DailyReturn":0.00093,"FiveDayReturnAfter":0.010179,"FiveDayReturnBefore":0.00271},{"Ticker":"CVX","EffectiveDate":"2013-03-13","Type":"RatingNeutral","Title":"Cowen & Co. maintains CVX to Buy. Target Price is $133; previously $129.","DailyReturn":0.00093,"FiveDayReturnAfter":0.010179,"FiveDayReturnBefore":0.00271},{"Ticker":"CVX","EffectiveDate":"2013-02-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.012507,"FiveDayReturnAfter":0.034198,"FiveDayReturnBefore":-0.012428},{"Ticker":"CVX","EffectiveDate":"2013-02-22","Type":"RatingNeutral","Title":"Canaccord Genuity initiates coverage on CVX to Buy. Target Price is $136.","DailyReturn":0.008436,"FiveDayReturnAfter":0.018611,"FiveDayReturnBefore":-0.004685},{"Ticker":"CVX","EffectiveDate":"2013-02-13","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":-0.000606,"FiveDayReturnAfter":-0.005291,"FiveDayReturnBefore":0.005941},{"Ticker":"CVX","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"UBS downgrades CVX to Neutral from Buy.","DailyReturn":-0.011159,"FiveDayReturnAfter":-0.007409,"FiveDayReturnBefore":0.002579},{"Ticker":"CVX","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Dahlman Rose maintains CVX to Buy. Target Price is $129; previously $120.","DailyReturn":-0.011159,"FiveDayReturnAfter":-0.007409,"FiveDayReturnBefore":0.002579},{"Ticker":"CVX","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Oracle Investment Research downgrades CVX to Hold from Buy. Target Price is $110.","DailyReturn":0.011724,"FiveDayReturnAfter":-0.001129,"FiveDayReturnBefore":-0.003034},{"Ticker":"CVX","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Societe Generale downgrades CVX to Hold from Buy. Target Price is $126.","DailyReturn":0.011724,"FiveDayReturnAfter":-0.001129,"FiveDayReturnBefore":-0.003034},{"Ticker":"CVX","EffectiveDate":"2013-02-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.011724,"FiveDayReturnAfter":-0.001129,"FiveDayReturnBefore":-0.003034},{"Ticker":"CVX","EffectiveDate":"2013-01-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.006484,"FiveDayReturnAfter":-0.012017,"FiveDayReturnBefore":0.011154},{"Ticker":"CVX","EffectiveDate":"2013-01-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.00849,"FiveDayReturnAfter":0.039644,"FiveDayReturnBefore":-0.007729},{"Ticker":"CVX","EffectiveDate":"2012-12-06","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Outperform. Target Price is $135; previously $130.","DailyReturn":0.012171,"FiveDayReturnAfter":0.027295,"FiveDayReturnBefore":-0.003889},{"Ticker":"CVX","EffectiveDate":"2012-12-06","Type":"RatingUpgrade","Title":"Dahlman Rose upgrades CVX to Buy from Hold. Target Price is $120.","DailyReturn":0.012171,"FiveDayReturnAfter":0.027295,"FiveDayReturnBefore":-0.003889},{"Ticker":"CVX","EffectiveDate":"2012-12-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.011639,"FiveDayReturnAfter":0.035716,"FiveDayReturnBefore":0.005597},{"Ticker":"CVX","EffectiveDate":"2012-12-05","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.011639,"FiveDayReturnAfter":0.035716,"FiveDayReturnBefore":0.005597},{"Ticker":"CVX","EffectiveDate":"2012-11-14","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":-0.018011,"FiveDayReturnAfter":-0.007886,"FiveDayReturnBefore":-0.047124},{"Ticker":"CVX","EffectiveDate":"2012-11-05","Type":"RatingNeutral","Title":"UBS maintains CVX to Buy. Target Price is $120; previously $125.","DailyReturn":0.007567,"FiveDayReturnAfter":-0.023622,"FiveDayReturnBefore":-0.012289},{"Ticker":"CVX","EffectiveDate":"2012-11-02","Type":"EarningsRevenueMiss","Title":"Before market open, CVX reports 2012 Q3's earning $2.69 per share and revenue $56000MM. This misses analyst's estimated EPS $2.83, misses estimated revenue $64090MM.","DailyReturn":-0.027723,"FiveDayReturnAfter":-0.051454,"FiveDayReturnBefore":0.018838},{"Ticker":"CVX","EffectiveDate":"2012-11-02","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.027723,"FiveDayReturnAfter":-0.051454,"FiveDayReturnBefore":0.018838},{"Ticker":"CVX","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Societe Generale maintains CVX to Buy. Target Price is $130; previously $131.","DailyReturn":-0.041837,"FiveDayReturnAfter":-0.028258,"FiveDayReturnBefore":-0.0051},{"Ticker":"CVX","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Dahlman Rose initiates coverage on CVX to Hold.","DailyReturn":-0.041837,"FiveDayReturnAfter":-0.028258,"FiveDayReturnBefore":-0.0051},{"Ticker":"CVX","EffectiveDate":"2012-10-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.002211,"FiveDayReturnAfter":-0.041665,"FiveDayReturnBefore":0.00315},{"Ticker":"CVX","EffectiveDate":"2012-10-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.015429,"FiveDayReturnAfter":-0.0051,"FiveDayReturnBefore":0.00877},{"Ticker":"CVX","EffectiveDate":"2012-10-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.015429,"FiveDayReturnAfter":-0.0051,"FiveDayReturnBefore":0.00877},{"Ticker":"CVX","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Bank of America maintains CVX to Neutral. Target Price is $125; previously $110.","DailyReturn":0.00592,"FiveDayReturnAfter":0.008033,"FiveDayReturnBefore":-0.010583},{"Ticker":"CVX","EffectiveDate":"2012-09-27","Type":"RatingNeutral","Title":"VTB Capital initiates coverage on CVX to Hold. Target Price is $120.","DailyReturn":0.007739,"FiveDayReturnAfter":-0.001376,"FiveDayReturnBefore":-0.002577},{"Ticker":"CVX","EffectiveDate":"2012-09-24","Type":"RatingUpgrade","Title":"Scotia Howard Weil upgrades CVX to Market Outperform from Market Perform.","DailyReturn":-0.00017,"FiveDayReturnAfter":-0.010583,"FiveDayReturnBefore":0.004681},{"Ticker":"CVX","EffectiveDate":"2012-09-20","Type":"RatingNeutral","Title":"JP Morgan maintains CVX to Neutral. Target Price is $123; previously $120.","DailyReturn":0.01072,"FiveDayReturnAfter":-0.002577,"FiveDayReturnBefore":0.018351},{"Ticker":"CVX","EffectiveDate":"2012-09-19","Type":"RatingNeutral","Title":"Credit Suisse maintains CVX to Outperform. Target Price is $135; previously $120.","DailyReturn":-0.003163,"FiveDayReturnAfter":-0.000342,"FiveDayReturnBefore":0.024143},{"Ticker":"CVX","EffectiveDate":"2012-08-15","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":0.001334,"FiveDayReturnAfter":-0.003922,"FiveDayReturnBefore":0.012163},{"Ticker":"CVX","EffectiveDate":"2012-08-06","Type":"RatingNeutral","Title":"Oppenheimer maintains CVX to Outperform. Target Price is $130; previously $120.","DailyReturn":0.00171,"FiveDayReturnAfter":0.021634,"FiveDayReturnBefore":0.016882},{"Ticker":"CVX","EffectiveDate":"2012-07-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.009144,"FiveDayReturnAfter":0.009012,"FiveDayReturnBefore":-0.005251},{"Ticker":"CVX","EffectiveDate":"2012-07-27","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CVX reports 2012 Q2's earning $3.56 per share and revenue $60000MM. This beats analyst's estimated EPS $3.24, misses estimated revenue $68560MM.","DailyReturn":0.009144,"FiveDayReturnAfter":0.009012,"FiveDayReturnBefore":-0.005251},{"Ticker":"CVX","EffectiveDate":"2012-07-12","Type":"RatingUpgrade","Title":"JP Morgan upgrades CVX to Neutral from Underweight. Target Price is $120.","DailyReturn":0.001717,"FiveDayReturnAfter":0.02849,"FiveDayReturnBefore":-0.023749},{"Ticker":"CVX","EffectiveDate":"2012-07-11","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Buy. Target Price is $120; previously $126.","DailyReturn":0.009338,"FiveDayReturnAfter":0.033605,"FiveDayReturnBefore":-0.018881},{"Ticker":"CVX","EffectiveDate":"2012-07-11","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.009338,"FiveDayReturnAfter":0.033605,"FiveDayReturnBefore":-0.018881},{"Ticker":"CVX","EffectiveDate":"2012-05-30","Type":"RatingNeutral","Title":"Oppenheimer maintains CVX to Outperform. Target Price is $120; previously $130.","DailyReturn":-0.026038,"FiveDayReturnAfter":-0.038129,"FiveDayReturnBefore":0.005501},{"Ticker":"CVX","EffectiveDate":"2012-05-30","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.026038,"FiveDayReturnAfter":-0.038129,"FiveDayReturnBefore":0.005501},{"Ticker":"CVX","EffectiveDate":"2012-05-16","Type":"Dividend","Title":"The Firm pays dividend $0.9","DailyReturn":0.001,"FiveDayReturnAfter":-0.006823,"FiveDayReturnBefore":-0.019043},{"Ticker":"CVX","EffectiveDate":"2012-04-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.000188,"FiveDayReturnAfter":-0.002168,"FiveDayReturnBefore":0.03555},{"Ticker":"CVX","EffectiveDate":"2012-04-25","Type":"EarningsRelease","Title":"Before market open, CVX reports 2012 Q1's earning $3.27 per share and revenue $58896MM..","DailyReturn":0.007959,"FiveDayReturnAfter":0.049607,"FiveDayReturnBefore":-0.00571},{"Ticker":"CVX","EffectiveDate":"2012-04-10","Type":"RatingNeutral","Title":"Citigroup maintains CVX to Buy. Target Price is $126; previously $124.","DailyReturn":-0.019712,"FiveDayReturnAfter":-0.019317,"FiveDayReturnBefore":-0.035315},{"Ticker":"CVX","EffectiveDate":"2012-04-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.019712,"FiveDayReturnAfter":-0.019317,"FiveDayReturnBefore":-0.035315},{"Ticker":"CVX","EffectiveDate":"2012-03-29","Type":"RatingNeutral","Title":"Morgan Stanley maintains CVX to Overweight. Target Price is $126; previously $137.","DailyReturn":0.009066,"FiveDayReturnAfter":-0.002743,"FiveDayReturnBefore":-0.018898},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.010744,"FiveDayReturnAfter":0.000933,"FiveDayReturnBefore":-0.01888},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.010744,"FiveDayReturnAfter":0.000933,"FiveDayReturnBefore":-0.01888},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010744,"FiveDayReturnAfter":0.000933,"FiveDayReturnBefore":-0.01888},{"Ticker":"CVX","EffectiveDate":"2012-03-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.010744,"FiveDayReturnAfter":0.000933,"FiveDayReturnBefore":-0.01888},{"Ticker":"CVX","EffectiveDate":"2012-02-29","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades CVX to Buy from Hold. Target Price is $130; previously $115.","DailyReturn":-0.00447,"FiveDayReturnAfter":-0.006958,"FiveDayReturnBefore":0.011008},{"Ticker":"CVX","EffectiveDate":"2012-02-15","Type":"Dividend","Title":"The Firm pays dividend $0.81","DailyReturn":-0.006434,"FiveDayReturnAfter":0.017075,"FiveDayReturnBefore":-0.003188}];